Global Cataract Surgery Devices Market Size Anticipated to Exceeds USD 1470.5 Billion by 2035 | CAGR of 5.33%

The Global Cataract Surgery Devices Market Size is foreseen to grow from USD 875.1 Billion in 2025 and is govern to reach around USD 1470.5 Billion by 2035. According to Spherical Insights , a detailed research report on the global cataract surgery devices market is boosted by the adoption of advanced and precision-based surgical technologies, accounting for nearly 30-35% share of the total share worldwide. Alcon is the prime player in the market with approximately USD 5.7-5.8 Billion in annual turnover and a 35-40% market share, positioning it as the primary driver of the global cataract surgery devices market.

 

 Market Snapshot

• Global Cataract Surgery Devices Market Size (2025): USD 875.1 Billion
• Projected Global Cataract Surgery Devices Market Size (2035): USD 1470.5 Billion
• Global Cataract Surgery Devices Market Compound Annual Growth Rate (CAGR): 5.33%
• Largest Growing Region: North America
• Fastest Regional Market: Asia Pacific
• 3^rd Largest Region: Europe
• Base Year: 2025
• Historical Period: 2021–2024
• Forecast Period: 2026–2035

Market Overview/ Introduction

The cataract surgery devices market is all about restoring clear vision to millions of patients as they age. It’s a specialised corner of eye care that focuses on the tools and tech used to replace a cloudy, natural lens with a clear, artificial one. This market is growing steadily as the world’s population gets older and conditions like diabetes, which can trigger cataracts earlier in life, become more common. The stars of this industry are Intraocular Lenses (IOLs), the minute implants that stay in the eye forever, and high-tech machines like phacoemulsification systems and precision femtosecond lasers that help surgeons work with incredible accuracy. While the U.S. and Europe currently dominate the way in which spending is done, the Asia-Pacific region is growing the fastest as more people in countries like India and China gain access to modern eye clinics. The main hurdles right now aren't the technology itself, but rather the high price tags on the latest equipment and a global shortage of trained surgeons to perform these life-changing procedures in remote areas.

Notable Insights: -

1. North America is anticipated to hold approximately 40% share of the global cataract surgery devices market over the predicted timeframe.
2. Asia Pacific is the fastest-growing region in the global cataract surgery devices market during the forecast period, holding approximately 30% share.
3. By product type, the intraocular lenses (IOLs) segment dominated the market and holds approximately 45% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
4. By end user, the hospitals segment dominated the market and holds approximately 52% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
5. The compound annual growth rate of the global cataract surgery devices market is 5.33%
6. The market is likely to achieve a valuation of USD 1470.5 Billion by 2035.

 

What is the role of technology in grooming the market?

Technology plays a crucial role in shaping the cataract surgery devices market by significantly improving surgical precision, safety, and patient outcomes. Advanced innovations such as femtosecond laser-assisted surgery and premium intraocular lenses (IOLs) have enhanced procedural accuracy by approximately 27%, while reducing complication rates and recovery time. Additionally, the integration of AI-based diagnostics and real-time imaging systems has increased early detection and surgical planning efficiency by nearly 20%, driving higher adoption rates of advanced cataract procedures globally.

 

 Market Drivers

The growth of this market is really being driven by a perfect storm of ageing and higher expectations. Since cataracts are a natural part of getting older, the global shift toward an ageing population means there is a massive, growing group of people who eventually need this help. At the same time, today’s seniors are more active than previous generations; they don't just want their sight back they want HD vision that lets them golf, drive, or read without being tethered to glasses. This has pushed companies to create incredible premium lenses that can fix multiple vision problems at once. We’re also seeing cataracts show up earlier in life due to the rise in diabetes and other health issues, which expands the patient pool even further. On top of that, the surgery itself has become much less intimidating. It’s moved out of the big, scary hospital setting and into small, efficient outpatient centres where the procedure is so fast and precise that people are often back home within a few hours.

 

Restrain

The cataract surgery devices market faces key restraints primarily due to the high cost of advanced surgical equipment and premium intraocular lenses, which limits adoption in price-sensitive and developing regions. Additionally, the shortage of skilled ophthalmic surgeons and the need for specialized training act as operational barriers. Stringent regulatory approval processes and limited reimbursement for premium procedures further restrict market growth, particularly in emerging economies.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the global cataract surgery devices market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Companies in the Global Cataract Surgery Devices Market

1. Alcon Inc.
2. Johnson & Johnson Vision
3. Bausch + Lomb
4. Carl Zeiss Meditec AG
5. HOYA Corporation
6. NIDEK Co., Ltd.
7. STAAR Surgical Company
8. Topcon Corporation
9. Ziemer Ophthalmic Systems AG
10. EssilorLuxottica

 

 

Government Initiatives

Country	Key Government Initiatives
India	National Programme for Control of Blindness & Visual Impairment (NPCBVI): Expands cataract surgery access nationwide. Ayushman Bharat Health Insurance: Covers cataract procedures for low-income patients. PLI Scheme (2023–2030): Incentivises domestic ophthalmic device manufacturing.
US	Medicare & Medicaid Coverage: Cataract surgery widely reimbursed, boosting procedure volumes. NIH & NEI Funding (approximately USD 48B annually): Supports R&D in ophthalmic devices, including intraocular lenses (IOLs) and femtosecond lasers
Japan	Universal Health Insurance: Covers cataract surgery with advanced devices. Government R&D Programs: Encourage adoption of femtosecond laser-assisted cataract surgery.

 

Study on the Supply, Demand, Distribution, and Market Environment of the Global Cataract Surgery Devices Market

The global cataract surgery devices market operates within a well-structured healthcare ecosystem where demand is primarily driven by the rising prevalence of cataracts and an ageing population, with over 183 million people affected by vision loss globally, significantly increasing surgical volumes. Supply is concentrated among a few major manufacturers with strong R&D capabilities, while hospitals dominate distribution channels, accounting for approximately 68% of total demand in 2024 due to advanced infrastructure and comprehensive care facilities. The market environment remains highly regulated and innovation-driven, with growing adoption of advanced technologies and outpatient surgical settings shaping overall market dynamics.

 

Price Analysis and Consumer Behaviour Analysis

Price analysis in the cataract surgery devices market reflects a wide cost variation driven primarily by the type of intraocular lens (IOL) and surgical technology used, with procedures ranging from USD 150 to over USD 7,000 per eye globally. Consumer behaviour is increasingly shifting toward premium solutions, as patients are willing to pay USD 1,200 3,000 extra for advanced IOLs to achieve better vision outcomes and reduce dependence on glasses. However, adoption remains selective, with only around 9% of patients opting for premium lenses, indicating that cost sensitivity still plays a significant role in decision-making, especially in emerging markets

 

Market Segmentation

The Global Cataract Surgery Devices Market is classified into product type, application, and end user.

• The intraocular lenses (IOLs) segment dominated the market and holds approximately 45% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the global cataract surgery devices market is divided into intraocular lenses (IOLs), phacoemulsification devices, femtosecond lasers, ophthalmic viscoelastic devices, and others. Among these, the intraocular lenses (IOLs) segment dominated the market and holds approximately 45% share in 2025 and is projected to grow at a substantial CAGR during the forecast period. This dominance is attributed to the essential role of IOLs in cataract surgery, as they replace the natural lens and restore vision. The increasing adoption of premium IOLs such as multifocal and toric lenses, which offer improved visual outcomes and reduced dependence on glasses, is further driving segment growth. Additionally, continuous innovation in lens materials and design is enhancing patient satisfaction and expanding adoption globally.

 

• The age-related cataract segment accounted for the largest share of approximately 65% in 2025 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the global cataract surgery devices market is divided into age-related cataract, congenital cataract, traumatic cataract, and others. Among these, the age-related cataract segment accounted for the largest share of approximately 65% in 2025 and is anticipated to grow at a significant CAGR during the forecast period. This is primarily due to the increasing global ageing population, as cataracts are highly prevalent among individuals aged 60 years and above. The rising awareness regarding early diagnosis and the availability of advanced surgical treatments is also contributing to the growth of this segment. For instance, large-scale screening programs and improved access to ophthalmic care are significantly increasing the number of cataract surgeries performed worldwide.

 

• The hospitals segment dominated the market and holds approximately 52% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the global cataract surgery devices market is divided into hospitals, ambulatory surgical centers, and ophthalmic clinics. Among these, the hospitals segment dominated the market and holds approximately 52% share in 2025 and is projected to grow at a substantial CAGR during the forecast period, owing to the availability of advanced surgical infrastructure, skilled ophthalmologists, and high patient inflow. Hospitals are the primary adopters of advanced cataract surgery devices, including phacoemulsification systems and femtosecond lasers, due to their ability to handle complex procedures. Additionally, the increasing number of cataract surgeries performed in hospital settings and the integration of advanced technologies for improved surgical outcomes are further supporting segment growth.

 

Strategies to Implement for Growth of the Market in Non-Leading Regions

To drive growth in non-leading regions, companies in the cataract surgery devices market should focus on developing cost-effective intraocular lenses and portable surgical systems, as high device and procedure costs limit adoption in nearly 57% of healthcare facilities in emerging markets. Expanding surgeon training programs and awareness initiatives is essential, as the shortage of skilled ophthalmologists remains a key barrier. Additionally, strengthening public-private partnerships and government-supported blindness control programs, along with offering flexible financing and mobile eye care units, can significantly improve access, especially in rural areas where over 50of untreated cataract cases are concentrated, thereby accelerating market penetration.

 

Regional Segment Analysis of the Global Cataract Surgery Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold approximately 40% share of the Global Cataract Surgery Devices Market over the predicted timeframe.

North America is anticipated to hold approximately 40% share of the global cataract surgery devices market over the predicted timeframe. It maintains a dominant market position due to advanced healthcare infrastructure, high adoption of minimally invasive cataract procedures, and the strong presence of key market players. The United States is the key contributor, supported by the rising prevalence of age-related cataracts and high healthcare expenditure. For instance, hospitals and ophthalmic clinics across the U.S. widely use advanced technologies such as phacoemulsification systems and premium intraocular lenses (IOLs) for improved visual outcomes. Additionally, continuous technological advancements and favourable reimbursement policies are further strengthening the region’s leadership.

 

Asia Pacific is the fastest-growing region in the Global Cataract Surgery Devices Market during the forecast period, holding approximately 30% share.

Asia Pacific is the fastest-growing region in the global cataract surgery devices market during the forecast period, holding approximately 30% share. This growth is driven by a large ageing population, increasing prevalence of cataracts, and rising healthcare investments in countries such as China, India, and Japan. The region is witnessing strong adoption of advanced cataract surgery devices due to improving healthcare infrastructure and growing awareness about vision care. For example, hospitals and eye care centres in India and China are increasingly adopting cost-effective intraocular lenses and phacoemulsification systems for high-volume surgeries. Additionally, government initiatives aimed at reducing blindness and expanding access to eye care services are accelerating market growth.

 

Europe is expected to hold approximately 25% share and is the third-largest region in the Global Cataract Surgery Devices Market during the forecast period.

Europe is expected to hold approximately 25% share and is the third-largest region in the global cataract surgery devices market during the forecast period. The region’s growth is supported by strong healthcare systems, increasing adoption of advanced surgical technologies, and a growing elderly population. Countries such as Germany, France, and the United Kingdom are leading the market due to rising demand for high-quality ophthalmic treatments. For instance, healthcare facilities across Europe are increasingly integrating femtosecond laser-assisted cataract surgery and premium intraocular lenses to enhance surgical precision and patient outcomes. Additionally, ongoing research and innovation by key medical device companies are contributing to market expansion.

 

Future Market Trends in the Global Cataract Surgery Devices Market:

1.  Adoption of Advanced & Premium Intraocular Lenses (IOLs)

The shift toward multifocal, toric, and extended depth of focus (EDOF) lenses is a major trend, improving vision quality and reducing dependence on glasses. The IOL segment already holds over 50%+ market share, and demand for premium lenses is rising as patients opt for better visual outcomes.

2. Growth of Femtosecond Laser-Assisted Cataract Surgery (FLACS)

Minimally invasive and highly precise procedures like FLACS are gaining traction due to improved surgical accuracy and faster recovery. This segment is projected to grow at an approximate 5–6% CAGR, outpacing traditional techniques as hospitals upgrade to laser-based systems.

3. Integration of Digital, AI, and Smart Surgical Platforms

The market is witnessing increasing adoption of AI-driven diagnostics, real-time imaging (OCT), and smart fluidics systems, enhancing surgical precision and workflow efficiency. These innovations are contributing to overall market growth,

 

Recent Development

 

• In March 2026, Alcon Inc. introduced next-generation digital cataract surgery platforms integrating advanced imaging and AI-assisted guidance, improving surgical precision and workflow efficiency.

 

• In January 2025, Johnson & Johnson Vision launched an advanced intraocular lens IOL portfolio with enhanced optical performance, supporting better visual outcomes for cataract patients.

 

• In October 2024, Carl Zeiss Meditec AG expanded its femtosecond laser systems for cataract surgery, focusing on improved accuracy and minimally invasive procedures.

 

• In August 2023, Bausch + Lomb received regulatory approval for a new premium intraocular lens, strengthening its presence in the advanced cataract treatment segment.

 

• In June 2023, HOYA Corporation introduced innovative preloaded IOL delivery systems, enhancing surgical efficiency and reducing procedure time in high-volume settings.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decision Advisors has segmented the global cataract surgery devices market based on the below-mentioned segments: 

 

Global Cataract Surgery Devices Market, By Product Type

• Intraocular Lenses (IOLs)
• Phacoemulsification Devices
• Femtosecond Laser Systems
• Ophthalmic Viscoelastic Devices (OVDs)
• Others

 

Global Cataract Surgery Devices Market, By Application

• Age-related Cataract
• Congenital Cataract
• Traumatic Cataract
• Others

 

Global Cataract Surgery Devices Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Ophthalmic Clinics

 

Global Cataract Surgery Devices Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

Q1. What is the average surgical success rate of modern cataract procedures?

A. Cataract surgeries have a high success rate of over 95%, with most patients experiencing significant vision improvement.

 

Q2. How many cataract surgeries are performed globally each year?

A. Approximately 28–30 million cataract surgeries are performed worldwide annually, making it one of the most common surgical procedures.

 

Q3. What is the average surgery waiting time in developing countries?

A. In many developing regions, patients may wait weeks to several months due to limited surgical infrastructure and specialist availability.

 

Q4. What percentage of cataract surgeries use laser-assisted techniques?

A. Currently, less than 15% of cataract surgeries globally use femtosecond laser-assisted technology due to higher costs.

 

Q5. What is the environmental impact of disposable cataract surgical devices?

A. Increasing use of single-use surgical consumables contributes to medical waste, prompting a growing focus on sustainable and reusable device solutions in the industry.